SCHEMBL21740530

SCHEMBL21740530

COC(=O)c1ccc(-c2ccc(/C=N/NCNNc3ccc(C(F)(F)F)cc3)o2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 3/20 0.52
MAPT P10636 8/20 0.48
NPC1 O15118 7/20 0.48
RAB9A P51151 6/20 0.48
MEN1 O00255 6/20 0.48
KMT2A Q03164 6/20 0.48
ALDH1A1 P00352 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 8/20 0.47
POLB P06746 4/20 0.43
CLEC4M Q9H2X3 1/20 0.42
GAA P10253 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
RECQL P46063 1/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292674 0.83 PHGDH (0.66) PHGDHMAPTNPC1RAB9AMEN1
SCHEMBL20115493 0.83 PHGDH (0.66) PHGDHMAPTNPC1RAB9AMEN1
SCHEMBL28373573 0.74 KEAP1 (0.67) PHGDHMAPTNPC1RAB9AMEN1
SCHEMBL28373575 0.74 KEAP1 (0.67) PHGDHMAPTNPC1RAB9AMEN1
SCHEMBL28373198 0.71 PHGDH (0.79) PHGDHMAPTNPC1RAB9AMEN1
SCHEMBL28373195 0.71 PHGDH (0.79) PHGDHMAPTNPC1RAB9AMEN1
SCHEMBL20115494 0.70 PHGDH (0.67) PHGDHMAPTNPC1RAB9AMEN1
SCHEMBL4323441 0.70 PHGDH (0.81) PHGDHMAPTNPC1RAB9AMEN1
SCHEMBL4323444 0.70 PHGDH (0.81) PHGDHMAPTNPC1RAB9AMEN1
SCHEMBL21292697 0.70 PHGDH (0.67) PHGDHMAPTNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885MAPT 3785/4885NPC1 4801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.